These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 16918974)
1. Nuclear maspin detection in renal cell tumours: possible diagnostic role and correlation with p53 status. Blandamura S; Giacomelli L; Leo G; Segato P; Ninfo V Histopathology; 2006 Sep; 49(3):274-82. PubMed ID: 16918974 [TBL] [Abstract][Full Text] [Related]
2. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications. Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemistry for the differential diagnosis of renal tumors with oncocytic features. Fernández-Aceñero MJ; Cazorla A; Manzarbeitia F Urol Oncol; 2011; 29(5):545-9. PubMed ID: 19926310 [TBL] [Abstract][Full Text] [Related]
4. Nuclear expression of maspin is associated with a lower recurrence rate and a longer disease-free interval after surgery for squamous cell carcinoma of the larynx. Marioni G; Blandamura S; Giacomelli L; Calgaro N; Segato P; Leo G; Fischetto D; Staffieri A; de Filippis C Histopathology; 2005 May; 46(5):576-82. PubMed ID: 15842640 [TBL] [Abstract][Full Text] [Related]
5. Differential expression of KAI1 metastasis suppressor protein in renal cell tumor histological subtypes. Kauffman EC; Barocas DA; Chen YT; Yang XJ; Scherr DS; Tu JJ J Urol; 2009 May; 181(5):2305-11. PubMed ID: 19303095 [TBL] [Abstract][Full Text] [Related]
6. Expression of vitamin D3 receptor in kidney tumors. Liu W; Tretiakova M; Kong J; Turkyilmaz M; Li YC; Krausz T Hum Pathol; 2006 Oct; 37(10):1268-78. PubMed ID: 16949927 [TBL] [Abstract][Full Text] [Related]
7. Expression of S-100 protein in renal cell neoplasms. Lin F; Yang W; Betten M; Teh BT; Yang XJ; Hum Pathol; 2006 Apr; 37(4):462-70. PubMed ID: 16564922 [TBL] [Abstract][Full Text] [Related]
8. Maspin in thyroid cancer: its relationship with p53 and clinical outcome. Boltze C; Schneider-Stock R; Meyer F; Peters B; Quednow C; Hoang-Vu C; Roessner A Oncol Rep; 2003; 10(6):1783-7. PubMed ID: 14534696 [TBL] [Abstract][Full Text] [Related]
10. Cytokeratins 7 and 20 immunoreactivity in chromophobe renal cell carcinomas and renal oncocytomas. Wu SL; Kothari P; Wheeler TM; Reese T; Connelly JH Mod Pathol; 2002 Jul; 15(7):712-7. PubMed ID: 12118108 [TBL] [Abstract][Full Text] [Related]
11. [Expression of maspin protein and correlation between maspin and P53 proteins in gastric carcinoma]. He Y; Zhang L; Li YJ; Ye F; Jiang Y; Jin XM Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(13):909-12. PubMed ID: 17650404 [TBL] [Abstract][Full Text] [Related]
12. The expression of heterochromatin protein 1α/β in the kidney tumors: a microarray immunohistochemical study. Han B; Ziober A; Lu S; Bing Z Ann Diagn Pathol; 2013 Apr; 17(2):172-5. PubMed ID: 23142018 [TBL] [Abstract][Full Text] [Related]
13. Nuclear morphometry as a tool of limited capacity for distinguishing renal oncocytoma from chromophobe carcinoma. Okoń K; Sińczak-Kuta A Pol J Pathol; 2008; 59(1):9-13. PubMed ID: 18655365 [TBL] [Abstract][Full Text] [Related]
14. [Role of the class II tumor suppressor gene maspin in thyroid carcinogenesis]. Boltze C; Hoang-Vu C; Schneider-Stock R; Lehnert H; Roessner A Verh Dtsch Ges Pathol; 2004; 88():237-45. PubMed ID: 16892558 [TBL] [Abstract][Full Text] [Related]
15. Chromophobe renal cell carcinoma: a comparative study of histological, immunohistochemical and ultrastructural features using high throughput tissue microarray. Abrahams NA; MacLennan GT; Khoury JD; Ormsby AH; Tamboli P; Doglioni C; Schumacher B; Tickoo SK Histopathology; 2004 Dec; 45(6):593-602. PubMed ID: 15569050 [TBL] [Abstract][Full Text] [Related]
16. Maspin expression in renal cell carcinoma and its correlation with clinicopathologic parameters. Turunc T; Bal N; Dirim A; Kuzgunbay B; Gul U; Ozkardes H Urology; 2010 Sep; 76(3):765.e8-13. PubMed ID: 20605199 [TBL] [Abstract][Full Text] [Related]
17. Paradoxical expression of maspin in gastric carcinomas: correlation with carcinogenesis and progression. Yu M; Zheng H; Tsuneyama K; Takahashi H; Nomoto K; Xu H; Takano Y Hum Pathol; 2007 Aug; 38(8):1248-55. PubMed ID: 17490717 [TBL] [Abstract][Full Text] [Related]
18. Nucleophosmin expression in renal cell carcinoma and oncocytoma. Sari A; Calli A; Altinboga AA; Pehlivan FS; Gorgel SN; Balci U; Ermete M; Dincel C; Cakalagaoglu F APMIS; 2012 Mar; 120(3):187-94. PubMed ID: 22339675 [TBL] [Abstract][Full Text] [Related]
19. Maspin, p53, p63, and Ki-67 in epithelial lesions of the tongue: from hyperplasia through dysplasia to carcinoma. Vered M; Allon I; Dayan D J Oral Pathol Med; 2009 Mar; 38(3):314-20. PubMed ID: 18783348 [TBL] [Abstract][Full Text] [Related]
20. Molecular differential diagnosis of renal cell carcinomas by microsatellite analysis. Bugert P; Kovacs G Am J Pathol; 1996 Dec; 149(6):2081-8. PubMed ID: 8952540 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]